tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Crinetics reports Q2 EPS ($1.23), consensus ($1.10)
PremiumThe FlyCrinetics reports Q2 EPS ($1.23), consensus ($1.10)
6d ago
3 Best Stocks to Buy Now, 7/22/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/22/2025, According to Top Analysts
22d ago
Crinetics Pharmaceuticals’ Palsonify Gains Positive Endorsement for Acromegaly Treatment with Promising Pipeline Expansion
Premium
Ratings
Crinetics Pharmaceuticals’ Palsonify Gains Positive Endorsement for Acromegaly Treatment with Promising Pipeline Expansion
23d ago
Crinetics Pharmaceuticals Presents at ENDO 2025 Meeting
PremiumCompany AnnouncementsCrinetics Pharmaceuticals Presents at ENDO 2025 Meeting
1M ago
3 Best Stocks to Buy Now, 6/30/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 6/30/2025, According to Top Analysts
1M ago
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Focus Drive Buy Rating
Premium
Ratings
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Focus Drive Buy Rating
2M ago
Crinetics Pharmaceuticals: A Promising Investment with Multiple Growth Opportunities
PremiumRatingsCrinetics Pharmaceuticals: A Promising Investment with Multiple Growth Opportunities
2M ago
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Positioning Justify Buy Rating
Premium
Ratings
Crinetics Pharmaceuticals: Promising Pipeline and Strategic Positioning Justify Buy Rating
3M ago
Crinetics treatment of carcinoid syndrome granted FDA orphan status
Premium
The Fly
Crinetics treatment of carcinoid syndrome granted FDA orphan status
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100